2-197402110-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 5P and 4B. PM1PM5PP5BS2
The NM_012433.4(SF3B1):āc.2098A>Gā(p.Lys700Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000449 in 1,604,090 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K700I) has been classified as Likely pathogenic.
Frequency
Consequence
NM_012433.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SF3B1 | NM_012433.4 | c.2098A>G | p.Lys700Glu | missense_variant | 15/25 | ENST00000335508.11 | |
SF3B1 | XM_047443838.1 | c.1660A>G | p.Lys554Glu | missense_variant | 12/22 | ||
SF3B1 | XM_047443839.1 | c.1660A>G | p.Lys554Glu | missense_variant | 12/22 | ||
SF3B1 | XM_047443840.1 | c.2098A>G | p.Lys700Glu | missense_variant | 15/22 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SF3B1 | ENST00000335508.11 | c.2098A>G | p.Lys700Glu | missense_variant | 15/25 | 1 | NM_012433.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152138Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000897 AC: 22AN: 245240Hom.: 0 AF XY: 0.0000979 AC XY: 13AN XY: 132820
GnomAD4 exome AF: 0.0000455 AC: 66AN: 1451952Hom.: 0 Cov.: 32 AF XY: 0.0000596 AC XY: 43AN XY: 721254
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152138Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74326
ClinVar
Submissions by phenotype
Chronic myelogenous leukemia, BCR-ABL1 positive Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Druker Lab, Oregon Health and Sciences University | Oct 10, 2022 | - - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2021 | - - |
Acute myeloid leukemia Pathogenic:1
Likely pathogenic, no assertion criteria provided | literature only | Database of Curated Mutations (DoCM) | Oct 02, 2014 | - - |
SF3B1-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 08, 2022 | The SF3B1 c.2098A>G variant is predicted to result in the amino acid substitution p.Lys700Glu. To our knowledge, this variant has not been reported in the literature in association with human disease. This variant is reported in 0.030% of alleles in individuals of Ashkenazi Jewish descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-198266834-T-C). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at